{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_16368", "batch_size": 200, "batch_pos": 146, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment confirms discussions about a 'pandemic flu candidate,' referring to the vaccine's purpose, not framing the current situation as a pandemic with high-potency language.", "method": "llm_batch", "batch_id": "batch_2_18668", "batch_size": 200, "batch_pos": 111, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "Segment does not contain a moderate verb paired with scale/impact information.", "method": "llm_batch", "batch_id": "batch_3_20148", "batch_size": 200, "batch_pos": 25, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_14392", "batch_size": 200, "batch_pos": 18, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "The segment reports discussions and lacks explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_8892", "batch_size": 200, "batch_pos": 12, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser used in conjunction with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_20084", "batch_size": 200, "batch_pos": 167, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "No bare negation present.", "method": "llm_batch", "batch_id": "batch_7_11240", "batch_size": 200, "batch_pos": 149, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "Describes capability/development ('in discussions... on advancing our pandemic flu candidate') from industry PR without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_17712", "batch_size": 200, "batch_pos": 74, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
